Dr Reddy's gets US FDA nod for marketing Ciprofloxacin

By Our Corporate Bureau | 17 Nov 2007

1

Mumbai: Dr Reddy's Laboratories Ltd has received approval from the US Food and Drug Administration to market its anti-infective Ciprofloxacin extended-release tablets.

The drug maker also received approval to market Rivastigmine Tartrate capsules, a generic variant of Novartis' Exelon capsules, indicated in the treatment of mild dementia associated with Alzheimer's disease and Parkinson's disease, USFDA said in statement in its website.

   

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers